J. Christopher Naftzger insider trades

Open-market stock purchases and sales by J. Christopher Naftzger, General Counsel and CCO at Arbutus Biopharma Corp, from SEC Form 4 filings since Jul 6, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ABUS Arbutus Biopharma Corp: 1 sale, last Feb 14, 2025
  • NBRV Nabriva Therapeutics plc: 1 buy, last Aug 11, 2022
  • UNIS Unilife Corp: 2 buys, last May 28, 2013

Get free alerts when J. Christopher Naftzger files a new trade →